PERCEPTIVE ADVISORS LLC
NEW YORK, NY · CIK 1224962 · 13F filing filed 2021-08-16
SEC-registered investment adviser since 2010 · limited liability company
- Assets managed$11.8bn
- Staff49 · 28 in investment roles
- Main clients (by assets)Private funds 99%
- Private funds17 (6 hedge) · $11.7bn gross assets
- Form ADV · 2026-07-13SEC adviser record
- Legal entityPERCEPTIVE ADVISORS LLC (US)
- Kindhedge funds, private equity, venture, futures
- Others nearbyNew York, NY, Greenwich, CT, Miami Beach, FL, Sheridan, WY, Water Mill, NY
As an employer
- Offices in1 country
- Private fundshedge 6, venture capital 2, private equity 5, other private 4
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 25 |
| Greenwich, CTUnited States | 1 |
| Miami Beach, FLUnited States | 1 |
| Sheridan, WYUnited States | 1 |
| Water Mill, NYUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 1 call positions ($33.3m notional), 1 put positions ($166.0k notional) – listed below, not included above.
Holdings, Q2 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| MIRATI THERAPEUTICS INC MRTX | $1.0bn6.70% | Added +2.9m |
| BRIDGEBIO PHARMA INC BBIO | $945.7m6.16% | Added +7.8m |
| SPRINGWORKS THERAPEUTICS INC SWTX | $799.4m5.20% | Added +4.8m |
| RETROPHIN INC TVTX 2.5 09.15.25 · principal | $768.8m5.00% | Added +45.0m |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $570.3m3.71% | Added +13.3m |
| AMICUS THERAPEUTICS INC FOLD | $445.8m2.90% | Added +23.4m |
| COLLEGIUM PHARMACEUTICAL INC COLL 2.625 02.15.26 · principal | $379.4m2.47% | Added +17.5m |
| HORIZON THERAPEUTICS PUB L HZNP | $371.8m2.42% | Added +1.9m |
| VBI VACCINES INC CDA COM NEW | $368.8m2.40% | Added +55.0m |
| LANDOS BIOPHARMA INC COM | $343.5m2.24% | Added +14.9m |
| INVITAE CORP NVTA | $325.1m2.12% | Added +4.3m |
| NEVRO CORP NVRO 2.75 04.01.25 · principal | $312.6m2.03% | Added +9.0m |
| ZYMEWORKS INC ZYME | $298.7m1.94% | Added +4.3m |
| GLOBAL BLOOD THERAPEUTICS IN GBT | $290.9m1.89% | Added +3.2m |
| NEVRO CORP NVRO | $271.5m1.77% | Added +825.4k |
| ROCKET PHARMACEUTICALS INC RCKT | $243.7m1.59% | Added +2.6m |
| OUTSET MED INC OM | $238.7m1.55% | Added +2.4m |
| CEREVEL THERAPEUTICS HLDNG I CERE | $237.9m1.55% | Added +4.6m |
| ALDEYRA THERAPEUTICS INC ALDX | $224.4m1.46% | Added +11.1m |
| UNITED THERAPEUTICS CORP DEL UTHR | $221.3m1.44% | Added +1.1m |
| MEIRAGTX HLDGS PLC MGTX | $215.4m1.40% | Added +7.0m |
| NAUTILUS BIOTECHNOLOGY INC NAUT | $180.0m1.17% | New |
| C4 THERAPEUTICS INC CCCC | $170.9m1.11% | Added +1.4m |
| SINGULAR GENOMICS SYSTEMS IN COM | $169.4m1.10% | New |
| ALBIREO PHARMA INC BIOD | $166.1m1.08% | Added +2.4m |
| PROMETHEUS BIOSCIENCES INC COM | $162.8m1.06% | Added +3.3m |
| NEUROCRINE BIOSCIENCES INC NBIX | $158.0m1.03% | Added +681.8k |
| RAPT THERAPEUTICS INC COM | $157.4m1.02% | Added +2.5m |
| CRINETICS PHARMACEUTICALS IN CRNX | $149.4m0.97% | Added +4.3m |
| RELAY THERAPEUTICS INC RLAY | $147.7m0.96% | Added +2.0m |
| BEAM THERAPEUTICS INC BEAM | $138.4m0.90% | Added +537.6k |
| ZYMERGEN INC ZY | $130.7m0.85% | New |
| COHERUS BIOSCIENCES INC CHRS | $129.9m0.85% | Added +4.7m |
| ATHENEX INC ATNX | $125.0m0.81% | Added +13.5m |
| ESTABLISHMENT LABS HLDGS INC ESTA | $122.3m0.80% | Added +413.5k |
| KADMON HLDGS INC KDMN | $121.6m0.79% | Added +15.7m |
| KRONOS BIO INC KRON | $121.1m0.79% | Added +2.3m |
| QUOTIENT LTD SHS | $117.9m0.77% | Added +16.2m |
| MACROGENICS INC MGNX | $115.4m0.75% | Added +2.1m |
| MEDTRONIC PLC MDT | $111.7m0.73% | New |
| MORPHIC HLDG INC MORF | $107.7m0.70% | Added +938.1k |
| SOLID BIOSCIENCES INC COM | $98.2m0.64% | Added +13.4m |
| ATEA PHARMACEUTICALS INC AVIR | $97.1m0.63% | Added +1.4m |
| COHERUS BIOSCIENCES INC CHRS 1.5 04.15.26 · principal | $92.1m0.60% | New |
| CAREMAX INC COM CL A | $85.7m0.56% | New |
| DBV TECHNOLOGIES S A SPONSORED ADR | $84.0m0.55% | Added +7.7m |
| APELLIS PHARMACEUTICALS INC APLS | $83.6m0.54% | New |
| VERRICA PHARMACEUTICALS INC COM | $81.6m0.53% | Added +3.6m |
| RAIN ONCOLOGY INC COM | $78.8m0.51% | New |
| TREACE MED CONCEPTS INC TMCI | $77.3m0.50% | New |
| TARSUS PHARMACEUTICALS INC TARS | $75.1m0.49% | Added +1.3m |
| AXSOME THERAPEUTICS INC AXSM | $74.7m0.49% | New |
| VERU INC COM | $71.8m0.47% | Added +4.5m |
| ATHIRA PHARMA INC COM | $70.2m0.46% | Added +3.4m |
| HEALTH CATALYST INC HCAT | $62.8m0.41% | Added +626.1k |
| XENON PHARMACEUTICALS INC XENE | $62.5m0.41% | Added +2.8m |
| DICERNA PHARMACEUTICALS INC DRNA | $59.7m0.39% | Added +800.0k |
| BIOATLA INC BCAB | $58.1m0.38% | New |
| EXACT SCIENCES CORP EXAS | $58.1m0.38% | Added +113.5k |
| IMMATICS N.V IMTX | $58.0m0.38% | Added +2.5m |
| INARI MED INC NARI | $57.9m0.38% | Added +55.8k |
| IVERIC BIO INC OPHT | $57.9m0.38% | Added +4.6m |
| ACCELERON PHARMA INC XLRN | $56.9m0.37% | New |
| NUVATION BIO INC NUVB | $56.6m0.37% | Added +3.0m |
| ALPHATEC HLDGS INC ATEC | $55.2m0.36% | Added +1.8m |
| TRAVERE THERAPEUTICS INC TVTX | $53.9m0.35% | Added +392.7k |
| GRAPHITE BIO INC GRPH | $53.8m0.35% | New |
| AVIDITY BIOSCIENCES INC RNA | $53.3m0.35% | Added +1.1m |
| KODIAK SCIENCES INC KOD | $53.2m0.35% | Added +183.1k |
| ADMA BIOLOGICS INC ADMA | $53.1m0.35% | Added +16.6m |
| REPLIGEN CORP RGEN | $52.9m0.34% | New |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $52.2m0.34% | Added +220.9k |
| LYRA THERAPEUTICS INC LYRA | $51.8m0.34% | Added +3.2m |
| COGENT BIOSCIENCES INC COGT | $51.7m0.34% | Added +3.2m |
| PMV PHARMACEUTICALS INC PMVP | $51.0m0.33% | Added +746.6k |
| INHIBRX INC INBX | $49.9m0.32% | New |
| CELLDEX THERAPEUTICS INC NEW CLDX | $49.7m0.32% | New |
| COLLEGIUM PHARMACEUTICAL INC COLL | $46.3m0.30% | Added +978.3k |
| FORTE BIOSCIENCES INC COM | $46.1m0.30% | Added +685.0k |
| STOKE THERAPEUTICS INC STOK | $45.2m0.29% | Added +672.0k |
| AGILE THERAPEUTICS INC AGRX | $42.3m0.28% | Added +15.9m |
| VYNE THERAPEUTICS INC COM | $40.5m0.26% | Added +4.8m |
| ONCORUS INC COM | $40.4m0.26% | Added +937.2k |
| CLOVER HEALTH INVESTMENTS CO CLOV | $40.0m0.26% | Added +1.5m |
| VERONA PHARMA PLC VRNA | $37.8m0.25% | Added +2.9m |
| DAY ONE BIOPHARMACEUTICALS I COM | $34.4m0.22% | New |
| 1LIFE HEALTHCARE INC COM | $34.1m0.22% | Added +512.2k |
| CM LIFE SCIENCES II INC UNIT 02/25/2028 | $33.6m0.22% | Added +1.2m |
| CATABASIS PHARMACEUTICALS IN CATB | $32.4m0.21% | Added +13.4m |
| NANOSTRING TECHNOLOGIES INC NSTG 2.625 03.01.25 · principal | $32.4m0.21% | New |
| IMMUNOCORE HLDGS PLC IMCR | $31.2m0.20% | Added +400.0k |
| NEPTUNE WELLNESS SOLUTIONS I NEPT | $30.1m0.20% | Added +12.8m |
| ACLARIS THERAPEUTICS INC ACRS | $29.9m0.19% | Added +1.1m |
| HEALTHCOR CATALIO ACQU CORP HYPR | $29.6m0.19% | Added +1.5m |
| NANOBIOTIX NBTX | $29.2m0.19% | Added +1.1m |
| VIRIDIAN THERAPEUTICS INC VRDN | $29.1m0.19% | New |
| ADAPTIVE BIOTECHNOLOGIES COR ADPT | $28.8m0.19% | Added +352.8k |
| VIATRIS INC VTRS | $28.7m0.19% | Added +1.0m |
| FUSION PHARMACEUTICALS INC COM | $28.7m0.19% | Added +1.6m |
| LEAP THERAPEUTICS INC LPTX | $27.8m0.18% | Added +8.5m |
Sold out since Q1 2021
| Security | Value then |
|---|---|
| ALLOGENE THERAPEUTICS INC ALLO | $40.4m1.1m shares |
| ARENA PHARMACEUTICALS INC ARNA | $39.9m575.0k shares |
| ACADIA PHARMACEUTICALS INC ACAD | $36.4m1.4m shares |
| FORMA THERAPEUTICS HLDGS INC | $35.0m1.2m shares |
| COMPASS PATHWAYS PLC CMPS | $29.4m797.4k shares |
| VAXCYTE INC PCVX | $16.8m850.0k shares |
| SYNDAX PHARMACEUTICALS INC SNDX | $6.0m270.0k shares |
| VINCERX PHARMA INC | $5.8m300.0k shares |
| PHREESIA INC PHR | $5.2m100.0k shares |
| DEERFIELD HEALTHCARE TECH AC | $3.9m300.0k shares |
| THERAPEUTICSMD INC TXMD | $3.7m2.8m shares |
| VIEWRAY INC VRAYQ | $3.3m751.7k shares |
| TALIS BIOMEDICAL CORP | $3.2m250.0k shares |
| VINCERA PHARMA INC | $1.2m300.0k shares |
| CEL-SCI CORP | $513.0k33.7k shares |
| SANA BIOTECHNOLOGY INC SANA | $335.0k10.0k shares |
| DEERFIELD HEALTHCARE TECH AC | $242.0k20.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| TELADOC HEALTH INC TDOC · Call | $33.3m200.0k shares | New |
| RAPT THERAPEUTICS INC Put | $166.0k90.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 38.
| Company | Stake |
|---|---|
| ADAGIO MED HLDGS INC ADGM · 13G · filed 2026-05-15 | 55.4%≈ $8.8m |
| LEONABIO INC LONA · 13D · filed 2026-10-26 | 20.0%≈ $17.4m |
| LYRA THERAPEUTICS INC LYRA · 13D · filed 2025-08-14 | 15.6% |
| MEIRAGTX HLDGS PLC MGTX · 13D · filed 2026-04-24 | 12.6%≈ $158.6m |
| SOLID BIOSCIENCES INC SLDB · 13D · filed 2026-08-14 | 11.2%≈ $120.3m |
| PERCEPTIVE CAP SOLUTIONS COR FRNM · 13G · filed 2026-07-23 | 10.1% |
| INHIBRX BIOSCIENCES INC INBX · 13G · filed 2026-08-14 | 10.0%≈ $141.1m |
| ALTO NEUROSCIENCE INC ANRO · 13G · filed 2026-08-14 | 10.0%≈ $110.2m |
| OPUS GENETICS INC IRD · 13G · filed 2026-08-14 | 10.0%≈ $37.6m |
| ENGENE HOLDINGS INC 13G · filed 2026-08-14 | 10.0% |
| KIORA PHARMACEUTICALS INC KPRX · 13G · filed 2026-08-10 | 10.0%≈ $1.2m |
| ENVVENO MEDICAL CORPORATION 13G · filed 2026-02-17 | 10.0% |
| ORCHESTRA BIOMED HLDGS INC OBIO · 13G · filed 2025-11-14 | 10.0%≈ $24.5m |
| TRINITY BIOTECH PLC 13D · filed 2026-05-04 | 9.9% |
| OUTSET MED INC OM · 13G · filed 2025-02-28 | 9.5% |
| NAUTILUS BIOTECHNOLOGY INC NAUT · 13D · filed 2026-08-14 | 9.1%≈ $21.8m |
| KARDIGAN INC KARD · 13D · filed 2026-10-01 | 8.8%≈ $196.9m |
| QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-10-14 | 8.4%≈ $1.7m |
| RESEARCH ALLIANCE CORP III RACC · 13G · filed 2026-05-28 | 8.2%≈ $8.0m |
| X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14 | 8.1%≈ $37.8m |
| SUTRO BIOPHARMA INC STRO · 13G · filed 2026-08-14 | 7.9%≈ $43.3m |
| PALISADE BIO INC PALI · 13G · filed 2026-05-15 | 7.9%≈ $29.5m |
| IMMATICS N.V IMTX · 13D · filed 2026-08-27 | 7.6%≈ $113.5m |
| AMYLYX PHARMACEUTICALS INC AMLX · 13G · filed 2026-05-15 | 7.5%≈ $148.8m |
| SAB BIOTHERAPEUTICS INC SABS · 13G · filed 2026-08-14 | 7.3%≈ $25.8m |
Trades reported as a company insider in Q2 2021
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2021-06-09 | NAUTILUS BIOTECHNOLOGY INC Former Director · See Footnote | Bought | $55.0m5.5m shares |
| 2021-06-03 | NAUTILUS BIOTECHNOLOGY INC Director · See Footnote | Bought | $3.3m330.1k shares |
| 2021-05-24 | NAUTILUS BIOTECHNOLOGY INC Former Director | Bought | $71.0k7.1k shares |
| 2021-05-20 | NAUTILUS BIOTECHNOLOGY INC Director · See Footnote | Bought | $1.6m159.9k shares |
| 2021-05-03 | ALDEYRA THERAPEUTICS INC 10% owner · See Footnote | Bought | $15.0m1.2m shares |